Cagent Vascular
PrivateLast Round
Series D
May 19, 2026
Total Funding Raised
$113.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cagent Vascular is a medical device company that develops and commercializes intravascular technology for the treatment of peripheral artery disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cagent Vascular Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cagent Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 19, 2026 | ||||
| Debt | Feb 20, 2025 | ||||
| Series C | Feb 19, 2024 | ||||
| Series B Extension | Jun 17, 2021 | ||||
| Series B | Jul 12, 2018 | ||||
Series A | Feb 28, 2017 |
Key People
Founding team and executive leadership
Cagent Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Series A, Series B |
| Tech-Synergy | Series B |
| U.S. Venture Partners | Series D, Series C |
| Synergy Ventures | Series B |
| Astoria Health Investors | Series D |
| Trinity Capital | Debt |
| Sectoral | Series C, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$41M round led by Astoria Health Investors and U.S. Venture Partners
- Apr 3, 2025
Partnered with 3comma Medical GmbH.
Cagent Vascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cagent Vascular's valuation, stock price, and market status.